Health and Technology
As a Venture Capital Management firm founded in 2008, we've honed our expertise in Health Technologies: biotech, medical devices and digital health.
Founded in 2008 by our seasoned, multi-disciplinary executive team and headquartered in Madrid and Barcelona, we are best positioned to reach most vibrant innovation hubs across Europe.
We are at the intersection between…
Fund I
Green Molecular
Pterostilbene formulations for derma and oncology
OWL Metabolomics
Metabolomic platform with first marketed non invasive diagnostic LDT for NASH.
nLife Therapeutics
Metabolomic platform with first marketed non invasive diagnostic LDT for NASH.
Fund II
Raman Health Technologies
Development of a diagnostic platform based on raman and infrared spectroscopy technology
Iden Biotechnology
Crop improvement (e.g. yield, resistance to biotic and abiotic conditions, and quality) throuigh genetic and biotechnology
Aglaris Cell
Novel bioreactor technology for automated mesenquimal and T-cell cultures.
Fund III: Digital Health III
Fund III's investment thesis is centered on the convergence of digital technologies and healthcare. We seek opportunities that span across platforms that bridge gaps in healthcare access and efficiency, diagnostic solutions that enhance precision, and treatment solutions that empower patients through digital interventions, providing better clinical outcomes. By strategically supporting founders, we aim to catalyze positive disruptions in the healthcare landscape.
Ticket size: 500k€ – 1.5M€, up to 4-5M€ per company.
Stage: Seed, Series A
Geography: Spain, Europe
